148 related articles for article (PubMed ID: 30147087)
1. Long term clinical outcomes of adult hematolymphoid malignancies treated at Tata Memorial Hospital: An institutional audit.
Khattry N; Laskar S; Sengar M; Rangarajan V; Shet T; Subramanian PG; Epari S; Bagal B; Goda JS; Agarwal A; Jain H; Tembhare P; Patkar N; Khanna N; Punatar S; Gokarn A; Shetty D; Jain H; Bonda A; Gota V; Hasan S; Kode J; Dutt S; Kulkarni S; Shetty N; Sable N; Deodhar J; Jadhav S; Pawaskar P; Mathew L; Menon H; Nair R; Kannan S; Chiplunkar S; Gujral S
Indian J Cancer; 2018; 55(1):9-15. PubMed ID: 30147087
[TBL] [Abstract][Full Text] [Related]
2. Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital.
Narula G; Prasad M; Jatia S; Subramanian PG; Patkar N; Tembhare P; Shetty D; Khanna N; Laskar S; Shet T; Epari S; Kembhavi S; Shah S; Qureshi S; Gujral S; Banavali SD
Indian J Cancer; 2017; 54(4):609-615. PubMed ID: 30082544
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
[TBL] [Abstract][Full Text] [Related]
4. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
5. A 14-year retrospective analysis of indications and outcomes of autologous haemopoietic stem cell transplantation in regional Queensland: a single-centre experience.
Hamilton EM; Nath KD; Vangaveti VN; McCutchan AD; Marsh JL; Birchley AJ; Casey JM; McNamara C; Lai HC; Morris ES; Hodges G; Irving IM
Intern Med J; 2020 Feb; 50(2):214-221. PubMed ID: 32037713
[TBL] [Abstract][Full Text] [Related]
6. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.
McCarthy PL; Hahn T; Hassebroek A; Bredeson C; Gajewski J; Hale G; Isola L; Lazarus HM; Lee SJ; Lemaistre CF; Loberiza F; Maziarz RT; Rizzo JD; Joffe S; Parsons S; Majhail NS
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1116-23. PubMed ID: 23660172
[TBL] [Abstract][Full Text] [Related]
7. Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.
Kusnierz-Glaz CR; Schlegel PG; Wong RM; Schriber JR; Chao NJ; Amylon MD; Hu WW; Negrin RS; Lee Y; Blume KG; Long GD
J Clin Oncol; 1997 Jan; 15(1):18-25. PubMed ID: 8996120
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double blind comparative study of prophylactic parenteral nutritional support with or without glutamine in autologous stem cell transplantation for hematological malignancies -- three years' follow-up.
Sykorova A; Horacek J; Zak P; Kmonicek M; Bukac J; Maly J
Neoplasma; 2005; 52(6):476-82. PubMed ID: 16284692
[TBL] [Abstract][Full Text] [Related]
9. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
10. Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country.
Ali N; Adil SN; Shaikh MU
Stem Cells Transl Med; 2015 Aug; 4(8):873-7. PubMed ID: 26032748
[TBL] [Abstract][Full Text] [Related]
11. Autologous peripheral blood stem cell transplantation in the patients with hematologic malignancies and solid tumors.
Ke X; Yang Y; Zhao X; Wang L
Chin Med J (Engl); 2001 Feb; 114(2):196-9. PubMed ID: 11780206
[TBL] [Abstract][Full Text] [Related]
12. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
13. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
14. [Eight years of experience in a single institution in hematopoietic stem cell autologous transplantation in malignant hematological diseases and in solid tumors].
Milone GA; Martínez Rolón J; Fernández II; Corrado CS; Desmery PM; Dignani MC; Juni M; Pavlovsky S
Medicina (B Aires); 2000; 60(1):115-24. PubMed ID: 10835708
[TBL] [Abstract][Full Text] [Related]
15. Hematological malignancies in East Africa-Which cancers to expect and how to provide services.
Leak SA; Mmbaga LG; Mkwizu EW; Mapendo PJ; Henke O
PLoS One; 2020; 15(5):e0232848. PubMed ID: 32374771
[TBL] [Abstract][Full Text] [Related]
16. Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors.
Gupta A; Gokarn A; Rajamanickam D; Punatar S; Thippeswamy R; Mathew L; Bagal B; Kannan S; Khattry N
J Cancer Res Ther; 2018; 14(5):926-933. PubMed ID: 30197327
[TBL] [Abstract][Full Text] [Related]
17. Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.
Persoon S; Kersten MJ; Chinapaw MJ; Buffart LM; Burghout H; Schep G; Brug J; Nollet F
BMC Cancer; 2010 Dec; 10():671. PubMed ID: 21134270
[TBL] [Abstract][Full Text] [Related]
18. [Autologous transplantation of peripheral blood hematopoietic stem cells in the treatment of hematological malignancies. I: patients].
Medinger P; Tissot JD; Nicoloso de Faveri G; Kovacsovics TJ; Perey L; Schneider P; Zwicky C
Schweiz Med Wochenschr; 2000 Apr; 130(13):478-84. PubMed ID: 10812643
[TBL] [Abstract][Full Text] [Related]
19. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Majolino I; Pearce R; Taghipour G; Goldstone AH
J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
[TBL] [Abstract][Full Text] [Related]
20. Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma.
Gordan LN; Sugrue MW; Lynch JW; Williams KD; Khan SA; Moreb JS
Bone Marrow Transplant; 2003 Jun; 31(11):1009-13. PubMed ID: 12774052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
